Bio Business

» cancer, pharma and tuberculosis

Most Recent

image: The CAR T-Cell Race

The CAR T-Cell Race

By | April 1, 2015

Tumor-targeting T-cell therapies are generating remarkable remissions in hard-to-beat cancers—and attracting millions of dollars of investment along the way.

1 Comment

image: Lazarus Drugs

Lazarus Drugs

By | February 1, 2015

While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.  

1 Comment

image: Outwitting the Perfect Pathogen

Outwitting the Perfect Pathogen

By | January 1, 2014

Tuberculosis is exquisitely adapted to the human body. Researchers need a new game plan for beating it.


image: The Little Cell That Could

The Little Cell That Could

By | July 1, 2012

Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.

1 Comment

image: Make Mine Rare

Make Mine Rare

By | August 1, 2011

With mounting interest from biotechs, Big Pharma, and the federal government, research on rare diseases is burgeoning.


image: Take Two of These

Take Two of These

By | June 22, 2011

Drugmakers are teaming up to test the disease-fighting power of combination therapies earlier in the development cycle than ever before.


image: The Profits of Nonprofit

The Profits of Nonprofit

By | January 1, 2011

The surprising results when drug development and altruism collide



Popular Now

  1. Antidepressant Exerts Epigenetic Changes
  2. Inside a Lab Mouse’s High-Fat Diet
  3. Image of the Day: Mother’s Love
  4. Gut Bugs to Brain: You’re Stuffed
Synthetic Genomics
Synthetic Genomics
Life Technologies